Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis
Felix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
The American Journal of Gastroenterology (2018) Vol. 113, Iss. 10, pp. 1475-1483
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1138
Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases
David W. Crabb, Gene Y. Im, Gyöngyi Szabó, et al.
Hepatology (2019) Vol. 71, Iss. 1, pp. 306-333
Open Access | Times Cited: 674
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Sandra Rebouissou, Jean‐Charles Nault
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 215-229
Open Access | Times Cited: 424
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Nathalie Ganne‐Carrié, Pierre Nahon
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 284-293
Open Access | Times Cited: 284
Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
Helene Gellert‐Kristensen, Tom G. Richardson, George Davey Smith, et al.
Hepatology (2020) Vol. 72, Iss. 3, pp. 845-856
Open Access | Times Cited: 186
The landscape of gene mutations in cirrhosis and hepatocellular carcinoma
Miryam Müller, Thomas G. Bird, Jean‐Charles Nault
Journal of Hepatology (2020) Vol. 72, Iss. 5, pp. 990-1002
Open Access | Times Cited: 141
Alcohol-associated liver disease
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 101
ACG Clinical Guideline: Alcohol-Associated Liver Disease
Loretta Jophlin, Ashwani K. Singal, Ramón Bataller, et al.
The American Journal of Gastroenterology (2023) Vol. 119, Iss. 1, pp. 30-54
Open Access | Times Cited: 58
PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis
Vincent Chen, Antonino Oliveri, Matthew J. Miller, et al.
Gastroenterology (2023) Vol. 164, Iss. 6, pp. 966-977.e17
Closed Access | Times Cited: 55
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Serena Pelusi, Guido Baselli, Alessandro Pietrelli, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 106
Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology
Silvia Sookoian, Carlos J. Pirola, Luca Valenti, et al.
Hepatology (2020) Vol. 72, Iss. 1, pp. 330-346
Open Access | Times Cited: 106
Hepatocellular Carcinoma in 2021: An Exhaustive Update
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 100
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases
Jie Yang, Eric Trépo, Pierre Nahon, et al.
International Journal of Cancer (2018) Vol. 144, Iss. 3, pp. 533-544
Open Access | Times Cited: 99
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers
Felix Stickel, Philipp Lutz, Stephan Buch, et al.
Hepatology (2019) Vol. 72, Iss. 1, pp. 88-102
Open Access | Times Cited: 98
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)
Juan Pablo Arab, Juan Pablo Roblero, José Altamirano, et al.
Annals of Hepatology (2019) Vol. 18, Iss. 3, pp. 518-535
Open Access | Times Cited: 97
A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease
Jie Yang, Eric Trépo, Pierre Nahon, et al.
Hepatology (2019) Vol. 70, Iss. 1, pp. 231-240
Closed Access | Times Cited: 93
Liver‐Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer
Elizabeth P. Newberry, Zoe Hall, Yan Xie, et al.
Hepatology (2021) Vol. 74, Iss. 3, pp. 1203-1219
Open Access | Times Cited: 88
Metabolic dysfunction–associated fatty liver disease and the risk of 24 specific cancers
Zhenqiu Liu, Chunqing Lin, Chen Suo, et al.
Metabolism (2021) Vol. 127, pp. 154955-154955
Closed Access | Times Cited: 71
Nonalcoholic fatty liver disease stratification by liver lipidomics
Olga Vvedenskaya, Tim Rose, Oskar Knittelfelder, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100104-100104
Open Access | Times Cited: 57
Alcohol-associated liver cancer
Yaojie Fu, Luca Maccioni, Xin Wei Wang, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1462-1479
Closed Access | Times Cited: 9
Genome-wide association study identifies high-impact susceptibility loci for HCC in North America
Manal M. Hassan, Donghui Li, Younghun Han, et al.
Hepatology (2024) Vol. 80, Iss. 1, pp. 87-101
Open Access | Times Cited: 8
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application
Vincent Chen, Graham F. Brady
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics
Silvia Sookoian, Carlos J. Pirola
Seminars in Liver Disease (2019) Vol. 39, Iss. 02, pp. 124-140
Open Access | Times Cited: 64
Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease
Luis Calzadilla Bertot, Leon A. Adams
Expert Review of Gastroenterology & Hepatology (2018) Vol. 13, Iss. 2, pp. 179-187
Closed Access | Times Cited: 63
PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
X. Charlie Dong
Frontiers in Medicine (2019) Vol. 6
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top